You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指升193點 醫藥及醫網股彈 阿裏健康飆逾11%
港股早市在騰訊(00700.HK)、匯控(00005.HK)及醫藥股帶動下造好。恆指高開30點,早段曾跌94點見23,399點,其後倒升243點一度高見23,737點,半日193升點或0.82%,報23,687點;國指升95點或1.16%,報8,326點;恆生科技指數升107點或1.95%,報5,611點。大市半日成交總額797.12億元,滬、深港通南下交易半日分別淨流入15.09億及11.93億元人民幣。 新冠變種Omicron在內地擴散,醫藥股見炒作。康希諾醫藥(06185.HK)升8.4%,中國中藥(00570.HK)、石藥(01093.HK)及中生製藥(01177.HK)各升5.8%至6.3%,醫療科網股京東健康(06618.HK)升11.6%,平安好醫生(01833.HK)及京東健康(06618.HK)各升8.6%及8.9%。 科技股方面,阿裏巴巴(09988.HK)回吐0.3%報128.4元,騰訊升2.4%報453.8元,美團(03690.HK)、小米(01810.HK)、百度(09888.HK)及網易(09999.HK)各升0.9%至1.7%,京東(09618.HK)及商湯(00020.HK)各升0.2%及0.5%。快手(01024.HK)彈9.7%報77.6元。 IGG(00799.HK)料2021年度淨利潤跌80%至90%,股價挫16.1%。舜宇(02382.HK)去年12月手機鏡頭出貨量年減7.3%,早市股價跌1.8%。電訊設備股中興(00763.HK)升5.5%。 國壽(02628.HK)董事長王濱涉嚴重違法受查,公司稱經營管理運作正常,股價逆跌1.8%報13.22元。美債孳息上週五(7日)曾升見1.8釐,本地銀行股匯控升2.6%報51.4元,恆生(00011.HK)及東亞(00023.HK)亦各升逾2%。港交所(00388.HK)升1.1%報454.4元,友邦(01299.HK)跌1.5%報79.8元。 內需股亦見追捧,中國旺旺(00151.HK)及中國飛鶴(06186.HK)各升5.9%及5.7%,萬洲(00288.HK)、康師傅(00322.HK)、恆安(01044.HK)、蒙牛(02319.HK)、藍月亮(06993.HK)及JS環球生活(01691.HK)各升3%至4%。 龍湖(00960.HK)建議分拆龍湖智創主板上市,股價升1.2%。據報廣東省推動國企收購有債務問題內房項目,雅居樂(03383.HK)及奧園(03883.HK)各升2.8%及2.6%,恆大(03333.HK)跌3.5%。內地物管股碧桂園服務(06098.HK)升5.9%,華潤萬象生活(01209.HK)及佳兆業美好(02168.HK)各升4.9%及4.8%。 其餘股份方面,申洲(02313.HK)反彈2.6%,創科(00669.HK)跌2.6%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account